Preclinical Molecular Imaging

Investigating new ways of molecular imaging in order to predict an individual patient’s response to treatment. Before moving to the ICR, she developed a new app

[The ICR @ICR_London]

📰 BREAKING: New imaging technique could spot patients with aggressive brain tumours who would benefit from #Immunotherapy

The immuno-PET imaging removes the need for a risky biopsy which means treatment for #Glioblastoma could be monitored and adjusted

https://t.co/UIwqgiFh2H

[Preclinical Molecular Imaging @PETImagingICR]

@TimWitney Congratulations 👏

[Preclinical Molecular Imaging @PETImagingICR]

We met to discuss the role of nuclear medicine in the treatment of brain tumours! Nathalie Albert&Matthias Preusser thanks for organising such a fantastic meeting!

[Preclinical Molecular Imaging @PETImagingICR]

Dr Julia Höbart. The gown really suits you❤️!

[Preclinical Molecular Imaging @PETImagingICR]

So incredibly proud of Dr Gitanjali Sharma! Viva passed with flying colours! Jason and Alan - thank you❤️!

[Preclinical Molecular Imaging @PETImagingICR]

@Allott_Lab Thanks and see you in London 😊

[Preclinical Molecular Imaging @PETImagingICR]

EANM 2023 - Vienna. Great meeting!
I am excited as I presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!

[The ICR @ICR_London]

🔬NEWS: A new form of screening may improve survival rates among people with glioblastoma #BrainTumours by helping to identify those most likely to benefit from certain types of #immunotherapy.

This pre-clinical research was led by @PETImagingICR.

https://t.co/lI2yTh8kF7

[The ICR @ICR_London]

Fantastic effort by Adam, who studies #ProstateCancer.

He's joined other ICR researchers, patients, ICR supporters, and Greg Rutherford and Erin Kennedy in taking on our race to #FinishCancer by collectively running 167,000 steps along the UK coastline.

https://t.co/qYXhoHMO9f

[The ICR @ICR_London]

A fantastic thread from @ErinWysocki on why her personal experience of cancer inspired her to take part in our new campaign and finish cancer. Thank you, Erin!

[Preclinical Molecular Imaging @PETImagingICR]

Super excited, as our recent paper was selected for a journal cover 🔥!

[Preclinical Molecular Imaging @PETImagingICR]

Very excited to share the paper that has been just published by my final year PhD student, Gitanjali Sharma 👏😊
https://t.co/srSq9ENPL1

[Preclinical Molecular Imaging @PETImagingICR]

Humans of Health Research Exhibition Launch... Happy to be part of it 😊!

[WMIS WIMIN @WIMIN_WMIS]

📢Call to Join the WIMIN Leadership Committee!

Enjoy our events at #WMIC? Want to get involved and help plan conference sessions and raise funds for attendees?

We are accepting applications to join our leadership committee, due Jan 13: https://t.co/VxmRxrcxC9

[Preclinical Molecular Imaging @PETImagingICR]

Happy Christmas Everyone 🌲🌲🌲!!!

[Preclinical Molecular Imaging @PETImagingICR]

Happy Halloween! Here we come again!

[The ICR @ICR_London]

We are proud to award the titles of Professor and Reader to 11 researchers from across the ICR and @royalmarsdennhs!

Titles were awarded for achievements in scientific and research careers, academic excellence, teaching and learning, service, and leadership 🎉

[Paweł Walewski @Walewski_P]

Nowa metoda leczenia #rak.a?
Poznajcie prof. Gabrielę #Kramer-Marek, która w @Polityka_pl mówi, jak #fotoimmunoterapia może pomóc chorym i jak doszła do swoich odkryć w USA, Londynie i Gliwicach.
@NIO_PIB @ICR_London @PETImagingICR @projektpulsar
⬇️⬇️⬇️
https://t.co/ztUntEtcDa

[Rossanese Lab @TEMT_ICR]

Come join us! We’re looking for an experienced in vivo biologist / pharmacologist to lead our in vivo drug discovery team & join us in discovering new cancer therapeutics. Experience with a wide range of in vivo models required. 💊🐁🧬

https://t.co/d0pT5ivjGV